EYEN Eyenovia Inc.

Eyenovia Inc is a clinical stage biopharmaceutical company. It is engaged in developing a pipeline of ophthalmology products utilizing patented piezo-print technology to deliver micro-therapeutics topically to the eye.

$5.44
As of 06/11/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  01/25/2018
Outstanding shares:  25,855,599
Average volume:  406,971
Market cap:   $139,620,235
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    30234E104
ISIN:        US30234E1047
Sedol:      BF8DJY2
Valuation   (See tab for details)
PE ratio:   -14.72
PB ratio:   11.48
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy